newsfilter
← Latest News
GlobeNewswire·

KemPharm Partners with the Hypersomnia Foundation to Support Sleep Disorder Research and Advocacy

CELEBRATION, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH) (KemPharm, or the Company), a rare disease therapeutics company focused on the development of treatments for rare central nervous system